L2C guinea pig leukemia: immunoprotection and immunotherapy.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000951:Antigens, Neoplasm; D006528:Carcinoma, Hepatocellular; D002460:Cell Line; D004247:DNA / Q000096:biosynthesis; D005260:Female; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular / Q000528:radiation effects; D007114:Immunization; D007116:Immunization, Passive; D007271:Injections, Intradermal; D007942:Leukemia, Experimental / Q000517:prevention & control; D007945:Leukemia, Lymphoid / Q000276:immunology / Q000517:prevention & control*; D008113:Liver Neoplasms; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000378:metabolism / Q000528:radiation effects; D008297:Male; D009368:Neoplasm Transplantation; D012882:Skin Tests; D014184:Transplantation, Homologous
D000906:Antibodies; D000951:Antigens, Neoplasm; D004247:DNA